News Video | Policy | GPs | Hospitals | Medical | Mental Health | Welfare | Search

 


Closed Systems for Handling Cytotoxic Drugs Acceptance


Led by Teaching Hospitals, Closed Systems for Handling Cytotoxic Drugs Gaining Acceptance

Greystone Research Associates Finds Awareness Among Caregivers is Growing, Creating Opportunities for System Suppliers

(Amherst, NH) – Paralleling the regulatory and standards-based trend that has driven the safety syringe market, caregivers in growing numbers are joining the ongoing dialogue about the benefits and issues related to the use of closed transfer systems for the preparation and delivery of hazardous drugs. These systems are designed to minimize the escape of particulates and vapors that can be released during the processing of drugs for IV administration and/or injection. Regulatory and industry efforts to create standards and procedures designed to protect workers and patients from accidental and incidental exposure to cytotoxics are being driven by data that suggests a causal link between exposure and health issues

The emerging market for these systems is dominated by oncology therapeutics and the cytotoxic drugs that still comprise a major segment of the drug therapies for the treatment of most cancers. While the sophistication of these chemical ‘cocktails ‘ has grown in recent years, and in spite of the increasing promise of targeted antibody treatments based on tumor-specific biomarkers, this segment continues to rely heavily on antineoplastics, a class that includes alkylating agents and antimetabolites. These cytotoxic drugs used to combat tumor cells can also harm normal cells and their DNA, and these drugs are believed to represent a significant occupational exposure risk for hospital pharmacy and infusion center personnel.

Several companies are responding to the need to protect caregivers as well as patients from the toxic effects of these substances by commercializing devices for the closed transfer of these drugs. As the market evolves and user acceptance increases, so too will the impact of these products on cytotoxic drug therapy protocols and drug delivery.


Detailed analysis of systems for the closed transfer of hazardous drugs is included in a new and comprehensive report. The report – Closed Drug Transfer Systems: Therapeutic Markets. Strategies and Outlook - includes assessments of devices and therapeutic market segments, analysis of market factors, and profiles of market participants.

More information is available at
http://www.greystoneassociates.org

About Greystone

Greystone Associates is a medical technology consulting firm focused on the areas of medical market strategy, product commercialization, venture development, and market research. We assist medical and healthcare market participants in achieving their business objectives through the creation of detailed development strategies, product commercialization programs, and comprehensive market and technology research and analysis. Our market research publications are designed, researched and written to provide timely and insightful information and data on focused market segments, with the aim of providing market participants with the essential knowledge to refine and execute their marketing plans and financial targets.

www.greystoneassociates.org

ENDS

© Scoop Media

 
 
 
 
 
Culture Headlines | Health Headlines | Education Headlines

 

Eddie Izzard: UK Comedy Legend Returns

Hailed as one of the foremost stand up comedians of his generation. Star of stage and screen. Tireless supporter of charity. Runner. Political campaigner. Fashion Icon... February 2015, Eddie Izzard will bring his massive FORCE MAJEURE world tour to New Zealand with tickets going on sale at 10am on Tuesday 28th October. More>>

Festival Starts 28 Oct: Improv Fest Makes Up New Show

For any other festival, finding out less than two weeks from showtime that half the cast of a programmed show can’t make it to New Zealand would be a nightmare. Instead, the New Zealand Improv Festival Director Jennifer O’Sullivan saw an opportunity ... More>>

NZ Music Awards Finalists: Lorde, Sol3 Mio Top 2014 Tuis Charge

Lorde has taken the music world by storm during the past year and she co-leads the 2014 Tui charge with five finalist spots. Joining her is newcomer family opera trio, Sol3 Mio. They are followed closely by Ladi6 and David Dallas, both up for four awards each. More>>

From 'Luther' Creator: Major New Zealand Crime Series For BBC

Libertine Pictures and writer Neil Cross have teamed up with leading international TV producer Carnival Films to develop a major new crime series set in Rotorua. Libertine will develop the contemporary drama series with Carnival, producer of internationally-acclaimed British period drama Downton Abbey, for the BBC. More>>

ALSO:

Family Statement: Death Of Ewen Gilmour

“Ewen was a much loved and cherished member of our family, he was a larger than life character and by his very nature was kind, generous and always giving of his time to those who asked for his help." More>>

ALSO:

Auckland: St. Jerome's Laneway Festival - Line-Up Announced

Traversing seven cities and three countries, the festival has well and truly settled into its home in each state. From the grassy knolls and towering silos at home in Auckland, to the sparkling backdrop of the Maribyrnong... More>>

Scoop Review Of Books: No Longer An Island

Simon Nathan reviews 'Zealandia: Our Continent Revealed': The idea that New Zealand is part of a large submerged continent is not new... There was renewed interest in the extent of offshore New Zealand from the 1970s onwards with the start of offshore drilling for oil and gas, and this was given impetus by a UN agreement which allowed countries to claim an Extended Continental Shelf (ECS). More>>

Art: Simon Denny Recreates Kim Dotcom’s Personal Effects

Who owns what? How has the internet changed our relation to the world? These are two of the many questions Simon Denny raises in the latest exhibition at the Adam Art Gallery, opening on Saturday 4 October. More>>

ALSO:

Get More From Scoop

 
 

LATEST HEADLINES

 
 
 
 
Health
Search Scoop  
 
 
Powered by Vodafone
NZ independent news